Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Colorectal Neoplasms

  Free Subscription


01.06.2026

1 Adv Exp Med Biol
1 Am J Surg
3 Ann Surg Oncol
4 Anticancer Res
5 BMC Cancer
2 BMC Gastroenterol
1 Cancer
1 Cancer Lett
1 Cancer Res
1 Clin Res Hepatol Gastroenterol
1 Dig Dis
3 Dis Colon Rectum
1 Eur J Gastroenterol Hepatol
7 Eur J Surg Oncol
3 Gastroenterology
1 Gut
2 Int J Cancer
4 Int J Colorectal Dis
2 J Clin Oncol
1 J Natl Cancer Inst
1 J Surg Oncol
1 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Exp Med Biol

  1. MOKOENA MP, Chelule PK, Rukasha I, Makhoba XH, et al
    The Role of Lactic Acid Bacteria in Colon Cancer Mitigation: Insights into Mechanisms of Action.
    Adv Exp Med Biol. 2026;1507:139-153.
    PubMed         Abstract available


    Am J Surg

  2. THOMAS AS, Duggan EM, Eyob B, Geller DA, et al
    Contemporary management of unresectable or borderline operable colorectal cancer liver metastases: a review and modern treatment algorithm.
    Am J Surg. 2026;259:117054.
    PubMed         Abstract available


    Ann Surg Oncol

  3. VALDES N, Albaladejo J
    Response to: "Comparable Does not Mean Equivalent: Causal Inference Gaps in Nutritional Prehabilitation for Malnourished Colorectal Cancer Patients".
    Ann Surg Oncol. 2026 May 27. doi: 10.1245/s10434-026-19866.
    PubMed        

  4. CANTURK AO, Altintoprak F
    Comparable Does Not Mean Equivalent: Causal Inference Gaps in Nutritional Prehabilitation for Malnourished Colorectal Cancer Patients.
    Ann Surg Oncol. 2026 May 26. doi: 10.1245/s10434-026-19860.
    PubMed        

  5. TANWEER MD, Raoof M
    ASO Author Reflections: Peritoneal Disease Control after Complete Cytoreductive Surgery in Patients with Colorectal Cancer and Extraperitoneal Metastases.
    Ann Surg Oncol. 2026 May 25. doi: 10.1245/s10434-026-19852.
    PubMed        


    Anticancer Res

  6. FUNAKOSHI K, Sasaki K, Hata K, Nozawa H, et al
    Genomic Profiling of Cancerous Areas, Dysplasia, and Background Mucosa in Ulcerative Colitis-associated Colorectal Cancer.
    Anticancer Res. 2026;46:3281-3291.
    PubMed         Abstract available

  7. MAEDA K, Koyama S, Kawada K, Hayashi T, et al
    Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan-Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer.
    Anticancer Res. 2026;46:3191-3203.
    PubMed         Abstract available

  8. RAFIQUE A, Koh YS
    Unveiling the Anti-tumor Actions and Therapeutic Potential of Calcitriol in Colorectal Cancer.
    Anticancer Res. 2026;46:2985-3004.
    PubMed         Abstract available

  9. MURAI Y, Sugimoto K, Irie T, Fujisaki T, et al
    Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer.
    Anticancer Res. 2026;46:3267-3280.
    PubMed         Abstract available


    BMC Cancer

  10. MARTIN-SANCHEZ C, Polo-Ferrero L, Mendez-Sanchez R, Puente-Gonzalez AS, et al
    8- versus 12-week supervised resistance training with home-based physical activity during colorectal cancer treatment: a pilot randomized dose-comparison trial.
    BMC Cancer. 2026 May 28. doi: 10.1186/s12885-026-16245.
    PubMed         Abstract available

  11. WANG Y, Jing Y, Yang Y, Zhang B, et al
    Clinicopathological, prognostic, and molecular differences between microsatellite-stable colorectal cancer patients aged 30 years.
    BMC Cancer. 2026 May 29. doi: 10.1186/s12885-026-16262.
    PubMed         Abstract available

  12. HONG Z, Chen S, Zhang C, Yu J, et al
    Impact of mucinous histology on the efficacy of neoadjuvant immunotherapy in localized mismatch repair-deficient colorectal cancer.
    BMC Cancer. 2026 May 27. doi: 10.1186/s12885-026-16231.
    PubMed         Abstract available

  13. LIN L, Chen Z, Zhang CY, Fang J, et al
    Role of glutathione disulfide reductase in colorectal cancer: a tumor suppressor.
    BMC Cancer. 2026 May 22. doi: 10.1186/s12885-026-16174.
    PubMed         Abstract available

  14. ZHANG LJ, Zhang CY, Li MX, Zhang D, et al
    Prognostic role of HSPs in human colorectal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2026 May 23. doi: 10.1186/s12885-026-16125.
    PubMed         Abstract available


    BMC Gastroenterol

  15. KARACAN E, Guven H, Kale H, Ersoy OF, et al
    Machine learning-based preoperative classification of colorectal cancer stage using systemic inflammatory and nutritional biomarkers.
    BMC Gastroenterol. 2026 May 25. doi: 10.1186/s12876-026-04962.
    PubMed         Abstract available

  16. XU S, Wan Q, Li T, Shu Y, et al
    Effect of remimazolam on postoperative delirium in elderly patients undergoing laparoscopic radical resection for colorectal cancer: a randomized controlled trial.
    BMC Gastroenterol. 2026 May 29. doi: 10.1186/s12876-026-04961.
    PubMed         Abstract available


    Cancer

  17. KONDO KK, Shiau RL, Troutman CAB, Griffin JC, et al
    Blood-based cell-free DNA and multitarget stool RNA screening tests to detect colorectal cancer: A systematic review.
    Cancer. 2026;132:e70428.
    PubMed         Abstract available


    Cancer Lett

  18. LI J, Luo Q, Xu C, Ding J, et al
    LINC01186-mediated deubiquitination of ACSL4 reprograms lipid metabolism to increase autophagy-mediated angiogenesis in colorectal cancer.
    Cancer Lett. 2026;655:218620.
    PubMed         Abstract available


    Cancer Res

  19. HAN S, Lv G, Hu P, Hu Y, et al
    Fusobacterium nucleatum Promotes Exosomal LncRNA MANCR Secretion from Colorectal Cancer Cells to Induce PD-L1 Expression in Macrophages.
    Cancer Res. 2026 May 27. doi: 10.1158/0008-5472.CAN-25-2167.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  20. SCHMITZ SM, Grunwald BT, Tasdogan A, Heise D, et al
    Impact of Metabolic Liver Disease on Colorectal Cancer and Liver Metastases: Pathophysiology and Implications for Hepatobiliary Surgery.
    Clin Res Hepatol Gastroenterol. 2026 May 25:102853.
    PubMed         Abstract available


    Dig Dis

  21. GOSAVI R, Bell S, Ooi G, McMurrick PJ, et al
    Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.
    Dig Dis. 2026 May 29:1-10. doi: 10.1159/000552644.
    PubMed         Abstract available


    Dis Colon Rectum

  22. WU GL, Horesh N, Ma R, La K, et al
    Preoperative Bowel Preparation Regimen and Postoperative Outcomes across Body Mass Index in Elective Colectomy for Colon Cancer: A Retrospective Cohort Study.
    Dis Colon Rectum. 2026 May 25. doi: 10.1097/DCR.0000000000004291.
    PubMed         Abstract available

  23. FUKUNAGA Y, Tsukada Y, Akiyoshi T, Yamaguchi T, et al
    Urinary Function After Laparoscopic Surgery in Very Low Rectal Cancer.
    Dis Colon Rectum. 2026;69:1741-1748.
    PubMed         Abstract available

  24. CHEUNG DC, Zhang C, Etzioni DA, Mi L, et al
    Financial Toxicity Following Locally Advanced Rectal Cancer Treatment.
    Dis Colon Rectum. 2026;69:1756-1765.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  25. DE SILVA R, Thomas JP, Murali N, Senathirajah L, et al
    The prevalence of nonmalignant gastrointestinal disease in patients with iron deficiency anemia: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2026;38:823-835.
    PubMed         Abstract available


    Eur J Surg Oncol

  26. DANILUK-MARSY P, Castelein J, Polom K, Borra RJH, et al
    Interpretable and non-linear machine learning models for quantitative ICG perfusion assessment in colorectal cancer anastomosis: A feasibility study.
    Eur J Surg Oncol. 2026;52:111911.
    PubMed         Abstract available

  27. WANG X, Jiang W, Sun Y, Tang Y, et al
    Distal margin length after neoadjuvant chemoradiotherapy has no prognostic impact in low rectal cancer once the margin is microscopically negative: A multicentre equivalence analysis.
    Eur J Surg Oncol. 2026;52:111465.
    PubMed         Abstract available

  28. SCARDINO A, Fiore M, Cavalleri T, Rausa E, et al
    The Inflammatory Biomarkers Prognostic Index (IBPI) obtained from standard preoperative blood tests predicts postoperative complications in patients undergoing pelvic exenteration for locally recurrent rectal cancer.
    Eur J Surg Oncol. 2026;52:111809.
    PubMed         Abstract available

  29. ZHOU J, Cui H, Lin Z, Qin S, et al
    The local efficacy of microwave ablation versus surgical resection for subcapsular colorectal liver metastases.
    Eur J Surg Oncol. 2026;52:111814.
    PubMed         Abstract available

  30. LAL N, Cheong Chung KJN, Hodges N, Jenkins JT, et al
    Prognostic significance of post-neoadjuvant MRI-detected extramural venous invasion and tumour deposits in rectal cancer: a systematic review and meta-analysis.
    Eur J Surg Oncol. 2026;52:111840.
    PubMed         Abstract available

  31. PAN Z, Zheng S, Zhuang Z, Wang Y, et al
    Development and validation of an ensemble machine learning model to predict survival in locally advanced rectal cancer: A multicenter, retrospective study.
    Eur J Surg Oncol. 2026;52:111815.
    PubMed         Abstract available

  32. HAN K, Zhou C, Zeng L, Lai X, et al
    MRI-driven multimodal deep learning approach for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A multicenter study.
    Eur J Surg Oncol. 2026;52:111796.
    PubMed         Abstract available


    Gastroenterology

  33. BEYER-BERJOT L, Delettrez C, Jacques J, Rouanet P, et al
    Transanal Endoscopic Microsurgery or Endoscopic Submucosal Dissection in Early Rectal Tumors: A Clinical and Cost-Effectiveness Analysis: The MUCEM Study.
    Gastroenterology. 2026;170:1533-1545.
    PubMed         Abstract available

  34. O'CONNOR G, Hazime H, Burgueno JF, Fernandez I, et al
    Quorum sensing molecules are elevated in long-standing ulcerative colitis and are linked to the development of colitis-associated cancer.
    Gastroenterology. 2026 Feb 11:S0016-5085(26)00090.
    PubMed         Abstract available

  35. SAMNANI S, Forbes N
    Risk of Colorectal Cancer following Colonoscopy in Older Persons.
    Gastroenterology. 2026 May 25:S0016-5085(26)06929.
    PubMed        


    Gut

  36. CAI R, Zhan W, Lyu X, Yang X, et al
    PTEN deficiency impairs MHC-I-mediated tumour immunity via NRF2-dependent autophagy in microsatellite stable colorectal cancer.
    Gut. 2026 May 22:gutjnl-2026-338195. doi: 10.1136/gutjnl-2026-338195.
    PubMed         Abstract available


    Int J Cancer

  37. LI Y, Zhang Y, Zhang W, Li R, et al
    Cost-Effectiveness of Initiating Colorectal Cancer Screening at Age 40 Among Average-Risk Individuals in China.
    Int J Cancer. 2026 May 25. doi: 10.1002/ijc.70563.
    PubMed         Abstract available

  38. TSAI YC, Wu CY, Hung TI, Chiou HY, et al
    Rising Incidence and Mortality of Colorectal Cancer Among Younger Adults: A Population-Based Study in Taiwan, 1994-2018.
    Int J Cancer. 2026 May 26. doi: 10.1002/ijc.70560.
    PubMed         Abstract available


    Int J Colorectal Dis

  39. LI X, Fu X, Zhang C, Li M, et al
    The predictive value of contrast-enhanced CT characteristics combined with composite inflammatory markers for lymph node metastasis in T1 colorectal cancer.
    Int J Colorectal Dis. 2026 May 29. doi: 10.1007/s00384-026-05159.
    PubMed         Abstract available

  40. ILHAN Y, Guzel HG
    Pulmonary metastasectomy in colorectal cancer: the importance of interpreting neoadjuvant strategies in the era of modern systemic therapy.
    Int J Colorectal Dis. 2026;41:92.
    PubMed        

  41. MIYAKE T, Kojima M, Tani S, Muramoto K, et al
    Gut microbiota profiles in reactive and metastatic lymphadenopathy in colorectal cancer: a tumor location-stratified analysis.
    Int J Colorectal Dis. 2026 May 25. doi: 10.1007/s00384-026-05154.
    PubMed         Abstract available

  42. SCHRAPS N, Nassar A, Zhang S, Zgurskyi P, et al
    Impact of socioeconomic status on patient characteristics and postoperative outcomes in colorectal cancer surgery: A retrospective cohort study.
    Int J Colorectal Dis. 2026;41:91.
    PubMed         Abstract available


    J Clin Oncol

  43. BROWN TJ, Ozer M, Grewal US, Hornstein NJ, et al
    Has Colorectal Cancer (c-)Met Its Match With Telisotuzumab Adizutecan?
    J Clin Oncol. 2026 May 27:JCO2600753. doi: 10.1200/JCO-26-00753.
    PubMed        

  44. DE LA FOUCHARDIERE C, Zaanan A, de Montfort A, Cohen R, et al
    Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP.
    J Clin Oncol. 2026;44:1520-1528.
    PubMed         Abstract available


    J Natl Cancer Inst

  45. RAIMONDI A, Tine G, Boige V, Ballhausen A, et al
    Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.
    J Natl Cancer Inst. 2026 May 22:djag160. doi: 10.1093.
    PubMed         Abstract available


    J Surg Oncol

  46. PICOTTO S, Seno E, Calabro M, Di Marzo M, et al
    Level of Vascular Ligation for Sigmoid Colon Cancer: Does It Matter? The Pina Low-T Study.
    J Surg Oncol. 2026 May 26. doi: 10.1002/jso.70291.
    PubMed         Abstract available


    Oncol Rep

  47. WU M, Zhang M
    Ferroptosis in colorectal cancer: Molecular mechanisms and regulatory crosstalk with therapeutic prospects (Review).
    Oncol Rep. 2026;56:138.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum